new_0222_0451|ORIC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0451|ORIC|1|ORIC Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|ORIC Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|ORIC Pharmaceuticals Inc Inventories (Quarterly) (USD)|ORIC Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|ORIC Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|ORIC Pharmaceuticals Inc Book Value (Quarterly) (USD)|ORIC Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|ORIC Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|ORIC Pharmaceuticals Inc EV to Revenues|ORIC Pharmaceuticals Inc EV to Earnings|ORIC Pharmaceuticals Inc EV to Free Cash Flow|ORIC Pharmaceuticals Inc EV to Assets (Quarterly)|ORIC Pharmaceuticals Inc PS Ratio|ORIC Pharmaceuticals Inc PE Ratio|ORIC Pharmaceuticals Inc Price to Book Value|ORIC Pharmaceuticals Inc PEG Ratio|ORIC Pharmaceuticals Inc Debt to Equity Ratio|ORIC Pharmaceuticals Inc Dividend Yield|ORIC Pharmaceuticals Inc Shareholder Yield (TTM)|ORIC Pharmaceuticals Inc Percent of Shares Outstanding Short|ORIC Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Payables (Quarterly) (USD)|ORIC Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|ORIC Pharmaceuticals Inc Return on Invested Capital|ORIC Pharmaceuticals Inc Quality Ratio Score|ORIC Pharmaceuticals Inc Momentum Score|ORIC Pharmaceuticals Inc Beta (1Y)|ORIC Pharmaceuticals Inc Sustainable Growth Rate (TTM)|ORIC Pharmaceuticals Inc Institutional Investor Ownership Percentage|ORIC Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|ORIC Pharmaceuticals Inc Total Employees (Annual)|ORIC Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|ORIC Pharmaceuticals Inc Shares Outstanding|ORIC Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|ORIC Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|ORIC Pharmaceuticals Inc Payout Ratio|ORIC Pharmaceuticals Inc Quick Ratio (Quarterly)|ORIC Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|ORIC Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|ORIC Pharmaceuticals Inc Effective Tax Rate (TTM)|ORIC Pharmaceuticals Inc Return on Equity|ORIC Pharmaceuticals Inc Net Income (TTM) (USD)|ORIC Pharmaceuticals Inc Revenue (TTM) (USD)|ORIC Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|ORIC Pharmaceuticals Inc Revenue (Quarterly) (USD)|ORIC Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|ORIC Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|ORIC Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|ORIC Pharmaceuticals Inc Net Income (Quarterly) (USD)|ORIC Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|ORIC Pharmaceuticals Inc Price (USD)|ORIC Pharmaceuticals Inc Total Return Price (USD)|ORIC Pharmaceuticals Inc Enterprise Value (USD)|ORIC Pharmaceuticals Inc 30-Day Average Daily Volume|ORIC Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0451|ORIC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0451|ORIC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0451|ORIC|5|91.2857142857|91.2857142857||91.2857142857||91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||||1.44662309368||||1.44444444444|||1.44662309368||15.2619047619||91.2857142857|91.2857142857|||30.7142857143|30.6666666667|||91.4|91.2857142857|91.4|28.1||91.2857142857|||91.4|91.4444444444|||91.2857142857|||||91.4|91.4|91.4|91.4|1.44565217391|1.44565217391|1.44662309368|1.44651162791|1.4347826087||
new_0222_0451|ORIC|6|7|7||7||7|7|7||7|7||||459||||414|||459||42||7|7|||7|9|||10|7|10|20||7|||10|9|||7|||||10|10|10|10|460|460|459|430|207||
new_0222_0451|ORIC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0451|ORIC|201903||||||||||||||||||||||||||||||||||19.1412||-0.3142||||||-0.3142|||||||||1.134|-6.015|-6.015|0.261|||||||
new_0222_0451|ORIC|201906||||||||||||||||||||||||||||||||||19.1412||-0.3116||||||-0.3116|||||||||1.315|-5.965|-5.965|0.317|||||||
new_0222_0451|ORIC|201909||||||||||||||||||||||||||||||||||19.1412||-0.3421||||||-0.3421|||||||||1.465|-6.549|-6.549|0.476|||||||
new_0222_0451|ORIC|201912|89.999|89.159||2.241||184.177|5.354|178.823||-90.084|-92.69|||||||||||||||0.152||||||||19.1412|57|-0.4364|||27.5424|||-0.4364||||-26.883|||||1.811|-8.354|-8.354|0.343|||||||
new_0222_0451|ORIC|202003|80.23|79.442||2.096||183.473|4.78|178.693||-98.417|-101.562||||-26.4117|||||||||2.2463||0.77||||||||27.5424|57|-0.3221|29.9174||27.5424|||-0.3221||||-29.74|||||1.925|-8.872|-8.872|0.241|26.45|26.45|711.8732|||29.02|
new_0222_0451|ORIC|202006|199.228|196.642||1.978||6.278|5.778|0.5||195.247|-112.586||||-26.3423||||5.1696|||||8.3772||1.389|0.003|||||||21.6274|58|-0.51|29.9245||29.9245|||-0.51|-138|||-34.799|||||3.4|-11.024|-11.024|0.025|33.73|33.73|812.7114|227338.8||20.07|25.05
new_0222_0451|ORIC|202009|189.058|186.61||1.893||7.287|6.928|0.359||184.375|-138.134||||-16.5409||||4.1434|||||7.0671||1.598|0.003||||||99.29|30.3149|60|-0.84|30.5452||30.5452|||-0.4121||||-53.798|||||3.8|-25.548|-25.548|0.01|25.01|25.01|577.3255|86746.0667||21.5|33.91
new_0222_0451|ORIC|202012|296.697|293.6||1.981||9.221|9.002|0.219||289.776|-166.393||||-20.6326||||4.2839|||||7.4055||0.757|0.004|||||||36.6724|61|-0.84|36.6724||36.6724|||-0.5163|-133.308|||-73.703|||||4.297|-28.259|-28.259|0.03|33.85|33.85|947.7607|357371.3||29.32|32.4
new_0222_0451|ORIC|202103|280.101|278.141||1.969||7.885|7.676|0.209||276.075|-182.902||||-11.7718||||3.2561|||||12.9547||0.606|0.004||||2.813|||36.6797|66|-0.45|36.6908||36.6908|||-0.45||||-81.34|||||4.856|-16.509|-16.509|0.044|24.5|24.5|620.7836|281814.8333|-8.7713|24.13|22.85
new_0222_0451|ORIC|202106|264.952|261.068||1.828||9.904|9.904|||258.323|-203.911||||-6.5505||||2.5143|||||15.0114||0.838|0.004|||2|2.9433|||36.7018|70|-0.57|36.7156||36.7156|||-0.57||||-91.325|||||5.54|-21.009|-21.009|0.033|17.69|17.69|388.431|257128.0333|-47.5541|16.65|22.09
new_0222_0451|ORIC|202109|292.849|289.519||1.825||22.644|11.903|10.741||291.536|-222.337||||-8.5893||||2.821|||||7.6523||0.419|0.004|||3|3.547|||39.0081|74|-0.47|39.3316||39.3316|||-0.47|-50|||-84.203|||||5.557|-18.426|-18.426|0.03|20.91|20.91|532.9048|215602.1333|-16.3934|14.64|13.84
new_0222_0451|ORIC|202112|||||||||||||||-4.6644||||1.9857|||||6.7399||||||2|-0.5106||||||||||||||||||||||||14.7|14.7|289.3949|177627.0667|-56.5731|9.89|8.41